Glutamate alterations associated with transcranial magnetic stimulation in youth depression: A case series

Journal of ECT

Volumn 30, Issue 3, 2014, Pages 242-247

  Yang, Xiao Ru ^a   Kirton, Adam ^b   Wilkes, Thomas Christopher ^a,b   Pradhan, Sarah ^a   Liu, Irene ^c   Jaworska, Natalia ^a   Damji, Omar ^b   Keess, Jamie ^b   Langevin, Lisa Marie ^a   Rajapakse, Thilinie ^b   Lebel, Robert Marc ^d   Sembo, Mariko ^a   Fife, Marilyn ^a   Macmaster, Frank P ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Department of Pediatrics ^*  (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d GE HEALTHCARE   (Canada)

Author keywords

adolescent; glutamate; magnetic resonance spectroscopy; major depressive disorder; repetitive transcranial magnetic stimulation

Indexed keywords

GLUTAMIC ACID;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN REGION; CHILD; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; YOUNG ADULT; DEPRESSIVE DISORDER, MAJOR; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

ADOLESCENT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84908356509     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0000000000000094     Document Type: Article

References (53)

1. Kondo DG, Hellem TL, Sung YH, et al. Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder. Depress Res Treat. 2011;2011:650450.
2. Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology, I: Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993;102:133-144.
3. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996;35:1427-1439.
4. Brent DA, Birmaher B. Treatment-resistant depression in adolescents: recognition and management. Child Adolesc Psychiatr Clin North America. 2006;15:1015-1034, x.
5. Brent DA. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step. Depression and anxiety. 2009;26:871-874.
6. Maalouf FT, Brent D, L Clark, et al. Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers. J Affect Disord. 2011;133:625-632.
7. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133:98-107.
8. Mitchell PB, Loo CK. Transcranial magnetic stimulation for depression. Aust N Z J Psychiatry. 2006;40:406-413.
9. Monaca C, Boutrel B, Hen R, et al. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology. 2003;28:850-856.
10. Croarkin PE, Wall CA, Lee J. Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry. Int Rev Psychiatry. 2011;23:445-453.
11. Rajapakse T, Kirton A. Non-invasive brain stimulation in children: applications and future directions. Translational Neuroscience. 2013;4:217-233.
12. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9:641-654.
13. Croarkin PE, Wall CA, McClintock SM, et al. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT. 2010;26:323-329.
14. Stanley JA. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can J Psychiatry. Revue canadienne de psychiatrie. 2002;47:315-326.
15. Maddock RJ, Buonocore MH. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci. 2012;11:199-251.
16. Rosen Y, Lenkinski RE. Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics. 2007;4:330-345.
17. Caverzasi E, Pichiecchio A, Poloni GU, et al. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol. 2012;27:13-22.
18. Farchione TR, Moore GJ, Rosenberg DR. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry. 2002;52:86-92.
19. Caetano SC, Fonseca M, Olvera RL, et al. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett. 2005;384:321-326.
20. MacMaster FP, Moore GJ, Russell A, et al. Medial temporal N-acetyl-aspartate in pediatric major depression. Psychiatry Res. 2008;164:86-89.
21. Olvera RL, Caetano SC, Stanley JA, et al. Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study. Psychiatry Res. 2010;184:71-76.
22. MacMaster FP, Kusumakar V. Choline in pediatric depression. Mcgill J Med. 2006;9:24-27.
23. Gabbay V, Hess DA, Liu S, et al. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry. 2007;164:1881-1889.
24. Smith EA, Russell A, Lorch E, et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry. 2003;54:1399-1405.
25. Mirza Y, Tang J, Russell A, et al. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry. 2004;43:341-348.
26. Rosenberg DR, MacMaster FP, Mirza Y, et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58:700-704.
27. Luborzewski A, Schubert F, Seifert F, et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res. 2007;41:606-615.
28. Zheng H, Zhang L, Li L, et al. High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1189-1195.
29. Michael N, Gosling M, Reutemann M, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. EurJ Neuroscience. 2003;17:2462-2468.
30. Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci. 2012;16:61-71.
31. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
32. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
33. Beck AT, Guth D, Steer RA, et al. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35:785-791.
34. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
35. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30: 672-679.
36. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260-264.
37. Kirton A, Deveber G, Gunraj C, et al. Cortical excitability and interhemispheric inhibition after subcortical pediatric stroke: plastic organization and effects of rTMS. Clin Neurophysiol. 2010;121: 1922-1929.
38. George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6:1853-1856.
39. George MS, Wassermann EM, Williams WA, et al. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 1996;8:172-180.
40. Herwig U, Satrapi P, Schonfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16:95-99.
41. Herwig U, Padberg F, Unger J, et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 2001;50:58-61.
42. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216.
43. Gilbert DL, Garvey MA, Bansal AS, et al. Should transcranial magnetic stimulation research in children be considered minimal risk? Clin Neurophysiol. 2004;115:1730-1739.
44. Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord. 2000;60:33-41.
45. Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety. 1996;4:160-168.
46. Pallanti S, Bernardi S. Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review. Int Clin Psychopharmacol. 2009;24:163-173.
47. Zwanzger P, Fallgatter AJ, Zavorotnyy M, et al. Anxiolytic effects of transcranial magnetic stimulation-an alternative treatment option in anxiety disorders? J Neural Transm. 2009;116:767-775.
48. Eschweiler GW, Wegerer C, Schlotter W, et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res. 2000; 99:161-172.
49. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603-1613.
50. Sibson NR, Shen J, Mason GF, et al. Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronal activity. Dev Neurosci. 1998;20:321-330.
51. Pfund Z, Chugani DC, Juhasz C, et al. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. J Cereb Blood Flow Metab. 2000;20:871-878.
52. Phan KL, Fitzgerald DA, Cortese BM, et al. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport. 2005;16:183-186.
53. Pollack MH, Jensen JE, Simon NM, et al. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:739-743.